secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001641172-25-015874
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel raises $3M via convertible preferred stock and warrants; cash runway into Q3 2025
--------------------------------------------------------------------------------

- Gross proceeds of $3.0M from sale of 3M shares of Series F Convertible Preferred at $1.00 per share.
- Each preferred share converts into 3.27 common shares; conversion requires stockholder approval per Nasdaq rules.
- Issued 29.43M warrants (Series A/B/C) at exercise prices $0.51, $0.60, $0.68, all expiring in 5 years.
- Net proceeds for working capital; combined with existing cash expected to fund operations into Q3 2025.
- Offering sold under Regulation S to non-U.S. accredited investors without a placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225015874/0001641172-25-015874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225015874/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer